Alzheimer'S Disease Clinical Trials in Miami, FL

Alzheimer'S Disease Clinical Trials in Miami, FL

View the best 10 alzheimer's disease medical studies in Miami, Florida. Access promising new therapies by applying to a Miami-based Alzheimer'S Disease clinical trial.

Trials in Miami, Florida

Here are the top 10 medical studies for alzheimer's disease in Miami, Florida

Image of MD First Research - Chandler in Chandler, United States.

BMS-986446

Monoclonal Antibodies

Recruiting0 awardsPhase 2
This trial is testing a new medication called BMS-986446 in people with early Alzheimer's disease. The medication is designed to target harmful proteins in the brain to slow down the disease. Researchers are checking if it works well and is safe for patients.
Image of Kingfisher Cooperative in Spokane, United States.

AR1001

Recruiting1 awardPhase 3
This trial tests AR1001, a medicine for early Alzheimer's Disease. It focuses on people in the early stages of Alzheimer's, aiming to improve their condition through multiple mechanisms.
Image of NYU Langone Health in New York, United States.

Exercise Routine

Behavioural Intervention

Recruiting1 award4 criteria
This trial is studying whether better sleep and more exercise can reduce the risk of dementia in people who are at risk. The idea is that these lifestyle changes might help keep the brain healthy.
Image of Noah Clinical Site 017 in Scottsdale, United States.

Polypill

Fixed Dose Combination

Recruiting0 awardsPhase 2
This trial aims to see how well a combination drug called a polypill works for patients with Alzheimer's Disease over 180 days. They will include male and female patients aged 50-85 with
Image of Banner Sun Health Research Institute in Sun City, United States.

Escitalopram

Selective Serotonin Reuptake Inhibitor

Recruiting2 awardsPhase 3
This trial will test whether the antidepressant escitalopram is effective and safe for treating agitation in Alzheimer's dementia.
Image of Novo Nordisk Investigational Site in Fullerton, United States.

Semaglutide +1 More

Glucagon-like peptide-1 (GLP-1) receptor agonist

Recruiting1 awardPhase 3
This trial is testing whether semaglutide has a positive effect on early Alzheimer's disease by comparing it to a placebo. There will be 17 clinic visits and 1 phone call with the study doctor, and various tests and scans will be performed. The study will last for up to 173 weeks.
Image of Mount Sinai Medical Center in Miami Beach, United States.

Brain CareNotes

Behavioural Intervention

Recruiting1 award3 criteria
This trial will test if a mobile health app can reduce the burden of unpaid Hispanic caregivers of dementia patients and improve BPSD symptoms in the care recipients.
Image of Weill Cornell Medicine in New York, United States.

ExAblate Model 4000 Type 2.0 System

Ultrasound Therapy

Recruiting1 award5 criteria
This trial is testing a device that uses ultrasound waves to temporarily open the brain's protective barrier in patients with Alzheimer's Disease. The goal is to see if this can help medications reach the brain better. Focused ultrasound with microbubbles has been studied recently and shows promise for opening the brain's protective barrier in Alzheimer's disease treatment.
Image of PROSOMNIA Sleep Health and Wellness in Aventura, United States.

PROSOMNIA Sleep Therapy™ (PSTx)

Behavioural Intervention

Recruiting1 awardPhase 1
This trial aims to test a new therapy called PROSOMNIA Sleep Therapy (PSTx) for people with chronic insomnia and REM sleep disorders. The therapy uses anesthesia to improve the quality and
Image of MD First Research - Chandler in Chandler, United States.

Donanemab

Monoclonal Antibodies

Recruiting1 awardPhase 3
This trial is testing different doses of donanemab, a drug aimed at helping people with early Alzheimer's disease. Donanemab has shown rapid reduction of brain amyloid in early Alzheimer's disease. The study will look at how often and how severely participants experience a side effect involving brain swelling. Researchers also want to find out which patient characteristics might predict this side effect.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.